2122-29-4 (（5alpha，7alpha）-spartein-5-ol,(5alpha,7alpha)-spartein-5-ol)

(5alpha,7alpha)-spartein-5-ol;(+)-Retamine;(1S,7aβ,14aα)-Dodecahydro-7β,14β-methano-2H,6H-dipyrido[1,2-a:1',2'-e][1,5]diazocin-1-ol;W1C646VHEF;A-methano-2H,6H-dipyrido[1,2-a:1',2'-e][1,5]diazocin-1-ol;A)-Dodecahydro-7;RETAMINE [MI];Retamine;UNII-W1C646VHEF;(1S,7a;A,14;A,14a;7,14-METHANO-2H,6H-DIPYRIDO(1,2-A:1',2'-E)(1,5)DIAZOCIN-1-OL, DODECAHYDRO-, (1S,7R,7AS,14R,14AS)-;2122-29-4;(1R, 2S, 3S, 9R, 10S)-7, 15-diazatetracyclo[7.7.1.02, 7.010, 15]heptadecan-3-ol;AKOS040753733;DTXSID80943582;NS00094232;CHEBI:8813;C10780;spartein-5-ol;(1S,7abeta,14aalpha)-Dodecahydro-7beta,14beta-methano-2H,6H-dipyrido[1,2-a:1',2'-e][1,5]diazocin-1-ol;

JMXNBIDTNISOTA-MRLBHPIUSA-N

1S/C15H26N2O/c18-14-5-3-7-17-9-11-8-12(15(14)17)10-16-6-2-1-4-13(11)16/h11-15,18H,1-10H2/t11-,12-,13+,14+,15+/m1/s1

O[C@H]1CCCN2C[C@H]3C[C@H](CN4CCCC[C@H]43)[C@H]21